{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:03:27Z","timestamp":1759104207313,"version":"3.44.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jneuroim.2021.577671","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T06:26:20Z","timestamp":1627107980000},"page":"577671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Initial serum GM-CSF levels are associated with the severity of cerebral small vessel disease in microscopic polyangiitis patients"],"prefix":"10.1016","volume":"359","author":[{"given":"Shin","family":"Ota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiichi","family":"Unoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimon","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2021.577671_bb0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet. Med."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/jir.2014.0149","article-title":"Dual role of GM-CSF as a pro-inflammatory and a regulatory cytokine: implications for immune therapy","volume":"35","author":"Bhattacharya","year":"2015","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MAJ.0b013e3182536789","article-title":"Microscopic polyangiitis with an initial presentation of pontine infarction","volume":"344","author":"Chen","year":"2012","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jneuroim.2021.577671_bb0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1568-9972(03)00010-7","article-title":"Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides","volume":"2","author":"Csernok","year":"2003","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1203\/00006450-199910000-00002","article-title":"The distribution of granulocyte-macrophage colony-stimulating factor and its receptor in the developing human fetus","volume":"46","author":"Dame","year":"1999","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0030","first-page":"362","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF): preclinical and clinical investigations","volume":"19","author":"Demetri","year":"1992","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s004670000428","article-title":"Microscopic polyarteritis with renal and cerebral involvement","volume":"15","author":"Deshpande","year":"2000","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0197-0186(96)00071-X","article-title":"Neurotrophins and their receptors in nerve injury and repair","volume":"30","author":"Ebadi","year":"1997","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0045","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/art.40815","article-title":"Performance of candidate serum biomarkers for systemic sclerosis-associated interstitial lung disease","volume":"71","author":"Elhai","year":"2019","journal-title":"Arthritis. Rheumatol."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis study group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jneuroim.2021.577671_bb0060","first-page":"1408","article-title":"Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis","volume":"29","author":"Hattori","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR (the European league against rheumatism) recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0070","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/jnnp-2016-315324","article-title":"Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries","volume":"88","author":"Hilal","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2021.577671_bb0075","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jlb.58.6.634","article-title":"The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications","volume":"58","author":"Hill","year":"1995","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13075-017-1429-3","article-title":"Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"19","author":"Ishizaki","year":"2017","journal-title":"Arthritis. Res. Ther."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0085","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-018-0824-5","article-title":"Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery","volume":"565","author":"Ito","year":"2019","journal-title":"Nature."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(07)60150-0","article-title":"Validation and refinement of scores to predict very early stroke risk after transient ischemic attack","volume":"369","author":"Johnston","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3171\/2008.12.JNS08172","article-title":"Reduction in programmed cell death and improvement in functional outcome of transient focal cerebral ischemia after administration of granulocyte-macrophage colony-stimulating factor in rats","volume":"111","author":"Kong","year":"2009","journal-title":"Lab. Investig. J. Neurosurg."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJM199207023270106","article-title":"Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1)","volume":"327","author":"Lieschke","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0115","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keab064","article-title":"CCL2 produced by CD68+\/CD163+ macrophages as a promising clinical biomarker of microscopic Polyanigiitis-interstitial lung disease","author":"Matsuda","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jneuroim.2021.577671_bb0120","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/annrheumdis-2012-201981","article-title":"Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis","volume":"72","author":"Monach","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0125","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis activity score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1447-0594.2010.00686.x","article-title":"Relationship between interleukin-6 and cerebral deep white matter and periventricular hyperintensity in elderly women","volume":"11","author":"Nagai","year":"2011","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.jneuroim.2021.577671_bb0135","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/156720209789630366","article-title":"Role of endogenous granulocyte-macrophage colony stimulating factor following stroke and relationship to neurological outcome","volume":"6","author":"Navarro-Sobrino","year":"2009","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1537-2995.1993.33193142315.x","article-title":"Granulocyte-macrophage-colony-stimulating factor: a review from preclinical development to clinical application","volume":"33","author":"Neumanaitis","year":"1993","journal-title":"Transfusion"},{"key":"10.1016\/j.jneuroim.2021.577671_bb0145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2014.02.016","article-title":"Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization","volume":"152","author":"Ohlsson","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0150","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/0271678X20941393","article-title":"Interleukin-4 improves white matter integrity and functional recovery after murine traumatic brain injury via oligodendroglial PPAR\u03b3","volume":"41","author":"Pu","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0155","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbadis.2011.08.007","article-title":"Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammtion-related genetic variants","volume":"1822","author":"Raz","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jneuroim.2021.577671_bb0160","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar4550","article-title":"Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study","volume":"16","author":"Sada","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0165","first-page":"56","article-title":"An autopsy case of P-ANCA-positive microscopic polyangiitis with multiple cerebral hemorrhagic infraction","volume":"50","author":"Sasaki","year":"1998","journal-title":"No To Shinkei"},{"key":"10.1016\/j.jneuroim.2021.577671_bb0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0022-510X(93)90041-V","article-title":"A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging","volume":"114","author":"Scheltens","year":"1993","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0175","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1007\/s00415-019-09318-9","article-title":"Occurrence of cerebral small vessel disease at diagnosis of MPO-ANCA-associated vasculitis","volume":"266","author":"Tani","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0180","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"A new rating scale for age-related white matter changes applicable to MRI and CT","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0185","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0190","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/art.40538","article-title":"Association between reappearance of myeloperoxidase-Antineutrophil cytoplasmic antibody and relapse in Antineutrophil cytoplasmic antibody-associated Vasculitis: subgroup analysis of Nationwide prospective cohort studies","volume":"70","author":"Watanabe","year":"2018","journal-title":"Arthritis. Rheumatol."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0195","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.autrev.2016.07.016","article-title":"The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA)","volume":"15","author":"Weiner","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.04.020","article-title":"Gradient echo T2*-weighted magnetic resonance imaging revealing cerebral microbleeds in a patient with microscopic polyangiitis complicated by cerebrovascular disease","volume":"21","author":"Yamashiro","year":"2012","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0205","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000330","article-title":"The interleukin-4\/PPAR\u03b3 signaling axis promotes oligodendrocyte differentiation and remyelination after brain injury","volume":"17","author":"Zhang","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jneuroim.2021.577671_bb0215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.dadm.2017.01.001","article-title":"Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease","volume":"23","author":"Zhu","year":"2017","journal-title":"Alzheimers Dement (Amst)"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572821001983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572821001983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:39:12Z","timestamp":1759048752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572821001983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":43,"alternative-id":["S0165572821001983"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577671","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initial serum GM-CSF levels are associated with the severity of cerebral small vessel disease in microscopic polyangiitis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577671"}}